Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
26:45
October 25, 2025 - PBS News Weekend full episode
57:46
October 24, 2025 - PBS News Hour full episode
56:42
October 23, 2025 - PBS News Hour full episode
57:46
October 22, 2025 - PBS News Hour full episode
57:46
October 21, 2025 - PBS News Hour full episode
57:46
October 20, 2025 - PBS News Hour full episode
26:44
October 19, 2025 - PBS News Weekend full episode
26:44
October 18, 2025 - PBS News Weekend full episode
57:46
October 17, 2025 - PBS News Hour full episode
57:46
October 16, 2025 - PBS News Hour full episode
57:46
October 15, 2025 - PBS News Hour full episode
57:46
October 14, 2025 - PBS News Hour full episode